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Background: Prior studies have reported inconsistent findings regarding the link between antenatal depressive and anxiety 
symptomatology, with neonatal outcomes.
Objectives: The aim of the present study was to assess the possible association of prenatal depressive and anxiety symptoms, in the third 
trimester of pregnancy, with perinatal outcomes (birth weight of the newborn, Apgar score and the newborn’s admission in neonatal 
intensive care unit) in a sample of pregnant women, in Greece.
Patients and Methods: A total of 117 women from Athens, during the 32nd to 35th week of pregnancy, participated in the study. 
Demographic and obstetric history data, as well as neonatal outcomes, were recorded. Three self-administered psychometric scales (Beck 
depression inventory (BDI), Edinburg postnatal depression scale (EPDS) and beck anxiety inventory (BAI)) were used to evaluate in detail 
the prenatal depressive and anxiety symptoms. Descriptive statistics, Spearman’s Rho coefficients, Mann-Whitney U and Kruskal-Wallis 
testes were applied to analyze the data.
Results: On the basis of BDI, 81.1% of the sample showed minimal, 15.4% mild, 2.6% moderate and 0.9% severe depressive symptoms, 
respectively. Furthermore, 80.3% of the participants, scored on EPDS below the cut-off point for a likely diagnosis of depression. According 
to BAI scale, 43.6% showed minimal, 42.7% women mild, 10.3% moderate and 3.4% severe anxiety symptoms. No statistically significant 
correlations were found between depressive and anxiety symptoms and neonatal outcomes (birth weight, Apgar score and admission in 
neonatal intensive care unit).
Conclusions: Limited levels of prenatal depressive and anxiety symptoms do not seem to be associated with neonatal outcomes. In 
clinical practice, pregnant women, who suffer from low levels of prenatal depressive and anxiety symptoms, may be reassured, in respect 
of the adverse outcomes of these mood symptoms on the neonate.
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1. Background
Although pregnancy and childbirth are often viewed 
as periods of emotional well-being, the perinatal period 
is a time of substantial vulnerability to affective illness. 
Pregnancy does not protect women from depression and 
anxiety (1, 2). Pregnancy is a period of great disruption and 
adjustment of biological, psychological and social aspects, 
which can be a risk factor for the development, occurrence 
or recurrence of mental disorders (3). Research from the 
past two decades has suggested a link between prenatal 
depression and anxiety and adverse obstetric and neona-
tal outcomes, such as infant’s low birth weight (LBW) (4, 5). 
Prevalence rates of depressive symptoms, among women 
of childbearing age, range from 10% to 50% (6-10), depend-
ing on the instrument used and the demographic char-
acteristics of the study population. Previous studies from 
Greece have indicated that rates of prenatal depressive 
symptoms range from 11.5% to 47% (11-13). Firm estimates 
for prenatal anxiety symptoms do not exist, although past 
studies suggest that prevalence rates of prenatal anxiety 
symptoms are similar to those in the general population, 
affecting 6.6% - 52.9% (14-17). According to the world health 
organization (WHO), elevated levels of prenatal anxiety are 
observed during the first and third trimesters of pregnan-
cy (18). It therefore, appears that the estimates of prenatal 
depressive and anxiety symptoms prevalence rates vary. 
Comparisons across studies are complicated due to differ-
ences in study methodology and design, including use of 
various depression and anxiety screening instruments, 
variable time of depression and anxiety screening in preg-
nancy and differences in composition of the sample and 
sample sizes. As an example, in the study of Kurki et al. (14), 
prenatal anxiety symptomatology in 10 - 17 weeks of gesta-
tion was assessed by one question only (Are you tense or 
distressed?) and was observed in 16% of the study sample. 
On the other hand, in the study by Nasreen et al. (17), pre-
natal anxiety symptoms were estimated by a psychometric 
scale (STAI), during the third trimester of pregnancy and 
were observed in 26% (17).
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Research findings are inconsistent regarding the asso-
ciation between prenatal depression anxiety symptom-
atology and adverse neonatal outcomes, such as the LBW 
of the newborn, the low Apgar score and the newborn’s 
admission in neonatal intensive care unit (NICU). The al-
legations of possible association of psychological factors 
with LBW have been expressed for decades (4). Prenatal 
depression has been associated with LBW (17, 19, 20). 
However, contradicting findings have also been reported 
(21-25), possibly due to differences in study methodol-
ogy and design (e.g. different psychometric tools, diverse 
study samples). In two of the studies (19, 20) confirming 
the association of prenatal depressive symptoms and 
LBW, the study samples recruited individuals from disad-
vantaged (low socioeconomic status or minority groups) 
populations. Anxiety symptoms during pregnancy have 
been reported to be associated with LBW in several stud-
ies (16, 17, 26), while others have not confirmed this as-
sociation (22, 23, 27-29). A number of studies indicate an 
association between low Apgar score of the newborn and 
prenatal depression and anxiety (9, 22), while, in other 
studies, this association does not exist (22, 24, 25).
2. Objectives
The main aim of this investigation was to examine the 
association between prenatal depressive and anxiety 
symptoms with neonatal outcomes. Part of the aim of 
this study was the assessment of prenatal depressive and 
anxiety symptomatology in the third trimester of preg-
nancy, in a sample of pregnant women from Greece. As 
far as we know, no similar research has been conducted 
in Greece. The findings of this study will contribute to 
this research area, where there are conflicting research 
views, and will help even more health professionals in 
shaping a more comprehensive view on the issue, also in 
other countries besides Greece.
3. Patients and Methods
3.1. Study Design and Participants
During the study period, of all the pregnant women we 
encountered, 117 agreed to participate in this exploratory, 
longitudinal study. All of the subjects were recruited from 
the private medical sector and were in the third trimester 
of pregnancy. Inclusion criteria were pregnant women be-
tween 32nd to 35th weeks of gestation, which received rou-
tine prenatal care throughout pregnancy and were either 
of Greek origin or fluent in Greek language. We collected 
socio-demographic and obstetric data using a demograph-
ic questionnaire, which was administered to the women. 
The questionnaire included questions relating to age, eth-
nicity, education level, professional and economic status, 
number of pregnancies and children, and the health status 
of women. Prenatal depressive symptoms were assessed 
with the Beck depression inventory (BDI) and the Edinburg 
postnatal depression scale (EPDS). The BDI is a self-report 
rating scale, consisting of 21 categories of symptoms and 
behaviors. Each category describes a specific behavioral 
manifestation of depression and consists of 4 - 5 self-evalu-
ation statements, sequentially classified. These statements 
are classified to reflect the variation in severity of symp-
toms from none to maximum importance. Numeric val-
ues from 0 to 3 were set for each statement, to determine 
the degree of importance. Items are scored on a 0 - 3 scale, 
yielding a score range of 0 - 63, where higher scores indi-
cate greater depression severity. Scores in the range of 0 - 13 
indicate minimal depression, 14 - 19 mild depression, 20 - 28 
moderate depression and 29 - 63 severe depression (30). In 
the Greek version of the BDI, the internal consistency reli-
ability is satisfactory and the Cronbach’s index is α = 0.84 
(31). The EPDS is one of the most popular tools for perinatal 
depression evaluation. It is a widely used tool, with satisfac-
tory validity and reliability, both in prenatal and postnatal 
period populations (32). The ten-topic version of EPDS scale 
consists of statements describing depressive symptoms 
and have four possible answers, each graded according to 
the complaint’s severity or duration. The answers are grad-
ed from 0 to 3, while several of them are graded conversely 
and their total sum is calculated at the end. The instrument 
has been validated for Greece, with Cronbach’s index be-
ing α = 0.9 and cut off point 11 (33). Antenatal anxiety symp-
tomatology was assessed using the Beck anxiety inventory 
(BAI). The BAI is a self-administered scale consisting of 21 en-
tries of anxiety symptoms. The score of each entry ranges 
on a scale from 0 to 3, with an overall score range of 0 - 63, 
and the final rating scale consists of the sum of the degree 
of distress for each symptom. Scores of 0 - 7 represent mini-
mal anxiety, 8 - 15 mild anxiety, 16 - 25 moderate anxiety and 
26 - 63 severe anxiety (34).
Finally, a questionnaire containing questions about 
neonatal parameters (e.g. birth weight, admission to the 
NICU and Apgar score) was administered to the women 
to record neonatal outcomes.3.2. Data Collection
The participants were recruited during their routine 
follow up in the private medical sector, in the time pe-
riod between March to April 2012. Women completed 
questionnaires during their routine prenatal examina-
tion. The data collection process included two samplings 
in the same sample. The first sampling was carried out in 
the third trimester of pregnancy during 32nd to 35th week 
of pregnancy. The recording of demographic data and 
the completion of the BDI, EPDS and BAI were performed 
in this sampling. The second sampling was carried out on 
the first postpartum week, where the recording of neona-
tal parameters was performed and the sample consisted 
of 93 women. The reason of attrition probably could be 
attributed to the fact that the second phase of the study 
was taking place during the postpartum period. The re-
quirements of this particularly sensitive period, such as 
the care of the newborn, may have played the main rea-
son of attrition.
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3.3. Ethical Considerations
The study protocol was approved by the assembly of 
Athens University Medical School, Athens, Greece, Medi-
cal School, approval number 6761, for scientific and ethi-
cal standards. Information about the study protocol and 
the confidentiality of the data and the identity of each 
participant were written to the informed consent form 
that was signed by each participant.
3.4. Data Analysis
Descriptive statistics were calculated for initial data 
analysis. Because of failure of all continuous variables 
in Kolmogorov-Smirnov normality tests, Spearman’s 
Rho coefficients were calculated to define correlations 
between continuous variables and non-parametric tests 
(Mann-Whitney U and Kruskal-Wallis) were applied in or-
der to define significant relationships between the con-
tinuous and categorical variables. The BDI, EPDS, and BAI 
scores were used as continuous variables. All association 
testing was conducted assuming a 5% significance level 
and a two-sided alternative hypothesis, while statistical 
analyses were performed using SPSS software package 
version 17.0 (SPSS Inc., Chicago, IL, USA).
4. Results
The initial sample of this study comprised 117 women 
from 32nd to 35th week of pregnancy. Their average age 
was 32.61 ± 4.06 years and the vast majorities of them were 
Greek (93.2%), graduates of higher-education (65.0%) and 
married (95.7%) (Table 1).
Table 1.  Descriptive Statistics of the Initial Sample of Pregnant 
Women a,b
Participant Data Items Values
Age, y 32.61 ± 4.06
Nationality
Greek 109 (93.2)
Albanian 6 (5.1)
Other 2 (1.7)
Educational level
Less than high school diploma 3 (2.6)
High school diploma 38 (32.4)
Bachelor’s degree 76 (65.0)
Marital status
Married 112 (95.7)
Unmarried 5 (4.3)
Professional status
Employed 98 (83.8)
Unemployed 7 (6.0)
Housekeeping 12 (10.2)
Monthly family income, €
0 - 1000 26 (22.2)
1000 - 3000 66 (56.4)
3000 - 5000 17 (14.6)
More than 5000 8 (6.8)
Planned pregnancy
Yes 77 (65.8)
No 40 (34.2)
Fertilization in vitro
Yes 10 (8.5)
No 107 (91.5)
Week of pregnancy
32nd 55 (47.0)
33rd 25 (21.4)
34th 18 (15.4)
35th 19 (16.2)
Number of pregnancies
First 67 (57.3)
Second 37 (31.6)
Third 11 (9.3)
Fourth 1 (0.9)
Fifth 1 (0.9)
Number of children
None 74 (63.2)
One 36 (30.8)
Two 7 (6.0)
Hyperemesis (during pregnancy)
Yes 16 (13.7)
No 101 (86.3)
Hypertension (during pregnancy)
Yes 4 (3.4)
No 113 (96.6)
Diabetes mellitus (during pregnancy)
Yes 17 (14.5)
No 100 (85.5)
Placental abruption
Yes 14 (12.0)
No 103 (88.0)
Bleeding disorder (1st trimester)
Yes 18 (15.4)
No 99 (84.6)
Bleeding disorder (2nd trimester)
Yes 1 (0.9)
No 116 (99.1)
Bleeding disorder (3rd trimester)
Yes 3 (2.6)
No 114 (97.4)
History of depression
Yes 10
No 107
Received antidepressant treatment
Yes 3 (2.6)
No 114 (97.4)
History of anxiety disorder
Yes 11 (9.4)
No 106 (90.6)
Received anxiolytic treatment
Yes 3 (2.6)
No 114 (97.4)
a  N = 117.
b  Values are presented as No. (%) except age that is presented as mean 
± SD.
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Furthermore, in a proportion of 83.8% they were em-
ployed, with most of them (56.4%) having a monthly fam-
ily income from 1000 to 3000 €. Also, for 77 (65.8%) of the 
women in the sample this pregnancy was planned, while 
for 10 (8.5%) of them, in vitro fertilization was employed. 
The largest relative rate of the women (47.0%) in the 
sample in the initial phase of this study was at the 32nd 
week of pregnancy, which was the first for most of them 
(57.3%), while only 36 (30.8%) and seven (6.0%) of these 
women had one and two children, respectively. With re-
gard to health problems experienced by women during 
pregnancy, hyperemesis was recorded at a rate of 13.7%, 
hypertension in 3.4%, diabetes mellitus in 14.5% and pla-
cental abruption in 12.0%. Similarly, bleeding disorders 
were experienced by 15.4% of the pregnant women, in the 
first trimester of pregnancy, 0.9% in the second and 2.6% 
in the third trimester. An important parameter of this 
study was the exploration of pregnant women’s mental 
health. Therefore, 8.5% of the pregnant women reported 
a positive past history of depression, with three (2.6%) of 
them appearing to have received antidepressant treat-
ment. Similarly, 9.4% of the pregnant women reported 
a history of anxiety disorder, with three (2.6%) of them 
reporting having followed anxiolytic treatment (Table 1).
The mean BDI score was 9.75 ± 4.67. Ninety-five (81.1%) 
participants were identified as experiencing minimal de-
pressive symptoms, while 18 (15.4%) women showed mild, 
three (2.6%) moderate and one (0.9%), severe symptoms, 
respectively (Table 2).
The mean EPDS score was 6.77 ± 4.51. Ninety-four (80.3%) 
women showed absence of depression, while 23 (19.7%) 
indicated a likely diagnosis of depression (Table 2). The 
mean BAI score was 9.43 ± 6.37. Fifty-one (43.6%) par-
ticipants showed minimal anxiety symptoms, while 50 
(42.7%) women showed mild, 12 (10.3%) moderate and 
four (3.4%), severe, anxiety symptoms (Table 2). Participa-
tion in the second phase of the study (after childbirth) 
included 93 (79.48%) of the initial 117 women. Thereby, 
the average pregnancy week was 38 ± 1.35 weeks, for these 
women (N = 93), while births took place between the 34th 
and 40th week. The average duration of childbirth for all 
puerperants was 5.56 ± 4.55 hours. Fifty-three (57.0%) of 
them had a natural childbirth and 40 (43.0%) gave birth 
by cesarean section. Of the puerperants, who had natural 
birth (Ν = 53), 27 (50.9%) received analgesics and 43 (81.1%) 
received epidural anesthesia. Respectively, two (5.0%) of 
the women with cesarean section (N = 40) received gen-
eral anesthesia, during childbirth, and 38 (95.0%) epi-
dural anesthesia. At the same time, the average weight 
of the newborns (Ν = 93) was 3090.32 ± 456.13 gram. Ad-
mission to the NICU was deemed necessary for 18 (19.4%). 
One (1.2%) newborn had Apgar score 7, 19 (23.2%) had 8, 33 
(40.2%) had 9 and 29 (35.4%) had Apgar score 10.
4.1. Associations of Prenatal Depressive and Anxi-ety Symptoms With Neonatal Parameters
According to BDI score, non-significant associations 
were found with the newborn’s birth weight (Spearman’s 
rho = -0.052, P = 0.623), with its admission in NICU (Mann-
Whitney U test, P = 0.992) and the Apgar score (Kruskal-
Wallis test, P = 0.307) (Table 3).
Table 2.  Descriptive Statistics of Prenatal Depressive and Anxi-
ety Symptoms Occurrence in Pregnant Women a,b
Mood Symptoms No. (%) Mean ± SD
BDI 9.75 ± 4.67
Minimal depressive symptoms 95 (81.1)
Mild depressive symptoms 18 (15.4)
Moderate depressive symptoms 3 (2.6)
Severe depressive symptoms 1 (0.9)
EPDS 6.77 ± 4.51
Total EPDS score < 11 94 (80.3)
Total EPDS score > 11 23 (19.7)
BΑI 9.43 ± 6.37
Minimal anxiety symptoms 51 (43.6)
Mild anxiety symptoms 50 (42.7)
Moderate anxiety symptoms 12 (10.3)
Severe anxiety symptoms 4 (3.4)
a  Abbreviations: BAI, Beck anxiety inventory; BDI, Beck depression 
inventory; EPDS, Edinburg postnatal depression scale.
b  N = 117.
Table 3.  Associations of Prenatal Depressive and Anxiety Symptoms With Neonatal Outcomes a, b
BDI Score P EPDS Score P BAI Score P
Birth weight, g (Rho) -0.052 0.623 0.017 0.872 - 0.108 0.302
Admission in NICU - 0.992 - 0.918 - 0.375
Yes c 10.06 ± 5.50 - 5.94 ± 3.40 - 10.33 ± 6.72 -
No c 9.48 ± 4.29 - 6.27 ± 4.29 - 8.68 ± 5.79 -
Apgar score 0.307 0.434 0.542
7 c 7.00 ± 0.00 - 6.00 ± 0.00 - 9.00 ± 0.00 -
8 c 11.89 ± 6.09 - 7.26 ± 4.54 - 10.42 ± 6.94 -
9 c 9.18 ± 4.26 - 6.42 ± 3.91 - 8.15 ± 4.32 -
10 c 9.14 ± 4.09 - 5.34 ± 4.11 - 7.79 ± 5.82 -
a  Abbreviations: BAI, Beck anxiety inventory; BDI, Beck depression inventory; EPDS, Edinburg postnatal depression scale; NICU, neonatal intensive care 
unit.
b  N = 93.
c  The values are presented as mean ± SD.
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According to EPDS scores, non-significant associations 
were found with the newborn’s birth weight (Spearman’s 
rho = 0.017, P = 0.872), with its admission in NICU (Mann-
Whitney U test, P = 0.918), and the Apgar score (Kruskal-
Wallis test, P = 0.434) (Table 3). Non-significant associa-
tions were found between prenatal anxiety symptoms, 
as assessed by BAI scale and the newborn’s birth weight 
(Spearman’s rho = -0.108, P = 0.302), its admission in 
NICU (Mann-Whitney U test, P = 0.375), and its Apgar score 
(Kruskal-Wallis test, P = 0.542) (Table 3).
5. Discussion
Our findings suggest that prenatal depressive and 
anxiety symptoms were not associated with neonatal 
outcomes, such as birth weight of the newborn, Apgar 
score and the newborn’s admission in NICU. Therefore, 
in regard to the association of prenatal depression and 
anxiety symptoms with birth weight, our results mirror 
a number of previous studies (21-23, 25, 27-29). Other au-
thors have found different results (16, 17, 19, 20, 26). There 
are several possible explanations for these discrepan-
cies. First, there are differences in study methodology. 
More specifically, several of these studies include women 
who are of low income (16, 17, 20) or belong to minority 
groups (19), not all are of adult age and their level of edu-
cation is basic (16). As we have already reported, the status 
of our sample was not low socioeconomic, all the partici-
pants were adults, the majority were graduates of higher 
education and received regular prenatal care. Probably, 
the difference in socioeconomic status, in health care 
systems and in maternal and neonatal profiles, may ex-
plain the adverse results. Another finding that we con-
sider important in our study is that prenatal depressive 
and anxiety symptoms were not associated with Apgar 
score. This result is in agreement with previous studies 
(21, 22, 24, 25), although not all (9, 22). Several factors that 
may explain the inconsistency with our findings are the 
different moment at which took place the assessment of 
prenatal depression and anxiety symptomatology, the 
different screening instruments, as well as the different 
cultural background.
In this study, we also found no association between pre-
natal depressive and/or anxiety symptoms and the new-
born’s admission in NICU and we did not find any rela-
tionship. This concurs with the study of Setse et al. (2009) 
(10), although is contradicted by the study of Chung et 
al. (2001) (35). The sample of their study was 959 women 
from Hong Kong and they found that prenatal depres-
sive symptoms were associated with increased risk of 
newborn’s admission in NICU. Authors reported that it is 
unclear how a high score in a scale can interact with this 
indication and suggest further investigation.
The findings of our study should be interpreted with 
regard to a series of limitations. The sample size was 
not large enough, as well as the fact that, in the second 
phase, i.e. the period in which the recording of neona-
tal outcomes was performed, not all the initial sample 
participated. In addition, there was no selection in the 
population involved, i.e. no women were excluded from 
the study due to certain characteristics, such as patho-
logical obstetric history. Also, our sample comes from a 
large urban center and the majority of the women had 
a high educational level. Furthermore, it should be men-
tioned that the majority of our sample reported the oc-
currence of limited depressive and anxiety symptoms 
that did not reach the cut-off point of a mood disorder. 
These attritions may compromise the generalization of 
the findings.
In conclusion, the evidence from our study suggests 
that limited depressive and anxiety symptoms during the 
third trimester of pregnancy do not appear to affect neo-
natal outcomes, such as the newborn’s birth weight, the 
Apgar score and the newborn’s admission in the NICU. 
This could be reassuring in clinical practice for pregnant 
women who suffer prenatally from low to moderate lev-
els of prenatal depressive and anxiety symptoms. The 
present study confirms previous findings and contrib-
utes additional evidence in this field of research. As far as 
we know, no similar study has been conducted in Greece. 
One of the strengths of the study is that the assessment of 
prenatal depressive symptoms was based on two differ-
ent psychometric scales, with similar results, therefore 
strengthening our conclusions. We hope our findings 
will stimulate further research that would yield evidence 
in antepartum depressive and anxiety symptomatology 
and its possible association with neonatal outcomes. Fur-
ther research might assess prenatal depressive and anxi-
ety symptoms using a combination of self-administrated 
scales and clinical interviews, in all trimesters of preg-
nancy. Another interesting area of future research would 
be to investigate possible associations between prenatal 
psychopathology with other neonatal and obstetric pa-
rameters, such as neonate small for gestational age (SGA), 
preterm birth and mode of delivery.
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